TABLE 2.
Carcinoma Type | Correct | Incorrect | Indeterminate | Accuracy (%) | Number 100% accurate |
---|---|---|---|---|---|
Low-Grade | |||||
Adenocarcinoma NOS (n = 1) | 15 | 2 | 2 | 88.2 | 0 |
Secretory (n = 1) | 10 | 1 | 8 | 90.9 | 0 |
Neuroendocrine (n = 1) | 12 | 1 | 6 | 92.3 | 0 |
Oncocytic (n = 1) | 16 | 1 | 2 | 94.1 | 0 |
Polymorphous adenocarcinoma (n = 2) | 22 | 4 | 12 | 84.6 | 0 |
Other total (n = 6) | 75 | 9 | 30 | 89.3 | 0 |
Epithelial-Myoepithelial (n = 5) | 53 | 16 | 26 | 76.8 | 0 |
Mucoepidermoid (n = 6) | 95 | 8 | 11 | 92.2 | 2 |
Aciniccell(n = 14) | 227 | 16 | 23 | 93.4 | 7 |
Total | 450 | 49 | 90 | 90.2 | 9 |
High-Grade | |||||
Squamous cell (n = 1) | 18 | 1 | 0 | 94.7 | 0 |
Adenocarcinoma NOS (n = 4) | 61 | 9 | 6 | 87.1 | 1 |
Myoepithelial (n = 2) | 30 | 3 | 5 | 90.9 | 1 |
Mucoepidermoid (n = 2) | 33 | 1 | 4 | 97.1 | 1 |
Salivary duct (n = 13) | 189 | 30 | 28 | 86.3 | 5 |
Total | 331 | 44 | 43 | 88.3 | 8 |
Abbreviation: NOS, not otherwise specified.